An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection

Clinical trial NCT02016963 · COMPLETED

Trial details

NCT number: NCT02016963
Sponsor: Human Genome Sciences Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Therapeutic Treatment of Inhalation Anthrax

Start date: 2008-01-31
Primary completion: 2008-05-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.